azacitidine has been researched along with Immunoblastic Lymphadenopathy in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cho, J; Kim, SJ; Kim, WS; Kim, YJ; Yoon, SE | 1 |
| Cavelier, L; Pandzic, T; Sander, B; Tobiasson, M; Wahlin, BE | 1 |
| Bruneau, J; Cheminant, M; Delarue, R; Derrieux, C; Gaulard, P; Hermine, O; Kosmider, O; Lefrere, F; Lemonnier, F; Radford, I | 1 |
3 other study(ies) available for azacitidine and Immunoblastic Lymphadenopathy
| Article | Year |
|---|---|
Real-World Efficacy of 5-Azacytidine as Salvage Chemotherapy for Angioimmunoblastic T-cell Lymphoma.
Topics: Azacitidine; Humans; Immunoblastic Lymphadenopathy; Lymphoma, T-Cell; Retrospective Studies; Salvage Therapy | 2022 |
Angioimmunoblastic T-cell lymphoma and myelodysplastic syndrome with mutations in
Topics: Aged, 80 and over; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Azacitidine; Bone Marrow; Cyclophosphamide; Dioxygenases; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; DNA Methyltransferase 3A; DNA-Binding Proteins; Doxorubicin; Drug Resistance, Neoplasm; Female; Homeodomain Proteins; Humans; Immunoblastic Lymphadenopathy; Lymph Nodes; Lymphoma, T-Cell; Mutation; Myelodysplastic Syndromes; Prednisone; Proto-Oncogene Proteins; Repressor Proteins; Transcription Factors; Treatment Outcome; Vincristine | 2019 |
Efficacy of 5-azacytidine in a TET2 mutated angioimmunoblastic T cell lymphoma.
Topics: Aged; Antineoplastic Agents; Azacitidine; Dioxygenases; DNA Mutational Analysis; DNA-Binding Proteins; DNA, Neoplasm; Female; Humans; Immunoblastic Lymphadenopathy; Leukemia, Myelomonocytic, Chronic; Lymphoma, T-Cell, Peripheral; Mutation; Proto-Oncogene Proteins | 2015 |